Cooper Companies Inc (NYSE:COO) – Analysts at Northcoast Research increased their Q3 2018 earnings per share estimates for Cooper Companies in a note issued to investors on Friday. Northcoast Research analyst D. Keiser now anticipates that the medical device company will post earnings of $3.05 per share for the quarter, up from their previous estimate of $3.03. Northcoast Research also issued estimates for Cooper Companies’ Q4 2018 earnings at $3.11 EPS, Q1 2019 earnings at $2.65 EPS, Q2 2019 earnings at $3.12 EPS, Q3 2019 earnings at $3.28 EPS, Q4 2019 earnings at $3.34 EPS and FY2019 earnings at $12.39 EPS.

A number of other brokerages have also commented on COO. Stifel Nicolaus boosted their price target on Cooper Companies from $265.00 to $275.00 and gave the company a “buy” rating in a report on Tuesday, September 12th. J P Morgan Chase & Co reaffirmed a “hold” rating and issued a $235.00 target price on shares of Cooper Companies in a research report on Tuesday, September 12th. Robert W. Baird reaffirmed a “buy” rating and issued a $273.00 target price (up previously from $267.00) on shares of Cooper Companies in a research report on Tuesday, September 12th. Oppenheimer reaffirmed a “hold” rating and issued a $250.00 target price on shares of Cooper Companies in a research report on Tuesday, September 12th. Finally, Stephens reaffirmed an “equal weight” rating and issued a $250.00 target price (up previously from $235.00) on shares of Cooper Companies in a research report on Tuesday, September 12th. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $259.70.

Shares of Cooper Companies (COO) traded up $1.89 during trading on Monday, hitting $228.45. The stock had a trading volume of 774,200 shares, compared to its average volume of 427,958. The company has a market capitalization of $11,089.94, a price-to-earnings ratio of 23.31, a price-to-earnings-growth ratio of 1.83 and a beta of 0.54. Cooper Companies has a 12 month low of $169.39 and a 12 month high of $256.39. The company has a current ratio of 2.41, a quick ratio of 1.26 and a debt-to-equity ratio of 0.36.

Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, beating analysts’ consensus estimates of $2.64 by $0.01. The company had revenue of $561.50 million for the quarter, compared to analyst estimates of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The company’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.28 earnings per share.

In other Cooper Companies news, Director Gary S. Petersmeyer sold 3,977 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.60% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Advisory Services Network LLC increased its position in Cooper Companies by 30.6% during the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after buying an additional 107 shares during the last quarter. YorkBridge Wealth Partners LLC grew its position in shares of Cooper Companies by 2.1% in the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock valued at $126,000 after purchasing an additional 11 shares during the last quarter. Acrospire Investment Management LLC grew its position in shares of Cooper Companies by 50.0% in the second quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock valued at $144,000 after purchasing an additional 200 shares during the last quarter. Canada Pension Plan Investment Board acquired a new position in shares of Cooper Companies in the third quarter valued at approximately $163,000. Finally, Penserra Capital Management LLC grew its position in shares of Cooper Companies by 13.0% in the second quarter. Penserra Capital Management LLC now owns 884 shares of the medical device company’s stock valued at $211,000 after purchasing an additional 102 shares during the last quarter. 96.79% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Northcoast Research Comments on Cooper Companies Inc’s Q3 2018 Earnings (COO)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was copied illegally and reposted in violation of U.S. & international copyright laws. The correct version of this article can be accessed at https://www.watchlistnews.com/northcoast-research-comments-on-cooper-companies-incs-q3-2018-earnings-coo/1759933.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.